Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-24-001444
Filing Date
2024-12-06
Accepted
2024-12-06 17:32:07
Documents
1
Period of Report
2024-12-04

Document Format Files

Seq Description Document Type Size
1 e664062_4-duane.html 4  
1 e664062_4-duane.xml 4 3989
  Complete submission text file 0001193805-24-001444.txt   5552
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VITAL THERAPIES, INC. 15010 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128
Business Address
Nash Duane (Reporting) CIK: 0001591098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 241533355